![Table 2 from Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy | Semantic Scholar Table 2 from Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92ca627ad27c4272a46d6d62febb15ecd2a09629/4-Table2-1.png)
Table 2 from Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy | Semantic Scholar
![Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram](https://www.researchgate.net/profile/Sreyashi-Basu/publication/333839614/figure/tbl2/AS:858142606888961@1581608549667/Overall-response-rate-CR-CRi-PR-and-HI-by-baseline-characteristics.png)
Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram
![PDF] Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer: A Randomized Clinical Trial | Semantic Scholar PDF] Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer: A Randomized Clinical Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b69b299e42ca49585c4070db17f53396bee4a3b9/127-Table16-2-1.png)